2018-2023 Global Pediatric Brain Tumor Market Report (Status and Outlook)
![](/report_cover/10189/2018-2023-global-pediatric-brain-tumor-market-report-status-n-outlook_en.gif)
The report requires updating with new data and is sent in 48 hours after order is placed.
In this report, LP Information studies the present scenario (with the base year being 2017) and the growth prospects of global Pediatric Brain Tumor market for 2018-2023.
Pediatric brain tumors are masses or growths of abnormal cells that occur in a child's brain or the tissue and structures that are near it. Many different types of pediatric brain tumors exist — some are noncancerous (benign) and some are cancerous (malignant).
Treatment and chance of recovery (prognosis) depend on the type of tumor, its location within the brain, whether it has spread, and your child's age and general health. Because new treatments and technologies are continually being developed, several options may be available at different points in treatment.
Over the next five years, LPI(LP Information) projects that Pediatric Brain Tumor will register a xx% CAGR in terms of revenue, reach US$ xx million by 2023, from US$ xx million in 2017.
This report presents a comprehensive overview, market shares and growth opportunities of Pediatric Brain Tumor market by product type, application, key companies and key regions.
To calculate the market size, LP Information considers value generated from the sales of the following segments:
Segmentation by product type:
Research objectives
In this report, LP Information studies the present scenario (with the base year being 2017) and the growth prospects of global Pediatric Brain Tumor market for 2018-2023.
Pediatric brain tumors are masses or growths of abnormal cells that occur in a child's brain or the tissue and structures that are near it. Many different types of pediatric brain tumors exist — some are noncancerous (benign) and some are cancerous (malignant).
Treatment and chance of recovery (prognosis) depend on the type of tumor, its location within the brain, whether it has spread, and your child's age and general health. Because new treatments and technologies are continually being developed, several options may be available at different points in treatment.
Over the next five years, LPI(LP Information) projects that Pediatric Brain Tumor will register a xx% CAGR in terms of revenue, reach US$ xx million by 2023, from US$ xx million in 2017.
This report presents a comprehensive overview, market shares and growth opportunities of Pediatric Brain Tumor market by product type, application, key companies and key regions.
To calculate the market size, LP Information considers value generated from the sales of the following segments:
Segmentation by product type:
- Gliomas
- Mixed Neuronal-Glial Tumors
- Choroid Plexus Papilloma/Carcinoma
- Tumors Arising From Non-Neuroepithelial Tissue
- Meningeal Tumors
- Hospitals And Clinics
- Medical Research Centers
- Academic Institutes
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Spain
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Abbott
- AbbVie
- Akorn
- Agios
- Baxter
- Bayer
- Epizyme
- Novartis
- Mylan
Research objectives
- To study and analyze the global Pediatric Brain Tumor market size by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2023.
- To understand the structure of Pediatric Brain Tumor market by identifying its various subsegments.
- Focuses on the key global Pediatric Brain Tumor players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
- To analyze the Pediatric Brain Tumor with respect to individual growth trends, future prospects, and their contribution to the total market.
- To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
- To project the size of Pediatric Brain Tumor submarkets, with respect to key regions (along with their respective key countries).
- To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.
- To strategically profile the key players and comprehensively analyze their growth strategies.
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Pediatric Brain Tumor Market Size 2013-2023
2.1.2 Pediatric Brain Tumor Market Size CAGR by Region
2.2 Pediatric Brain Tumor Segment by Type
2.2.1 Gliomas
2.2.2 Mixed Neuronal-Glial Tumors
2.2.3 Embryonal Tumors
2.2.4 Choroid Plexus Papilloma/Carcinoma
2.2.5 Tumors Arising From Non-Neuroepithelial Tissue
2.2.6 Meningeal Tumors
2.3 Pediatric Brain Tumor Market Size by Type
2.3.1 Global Pediatric Brain Tumor Market Size Market Share by Type (2013-2018)
2.3.2 Global Pediatric Brain Tumor Market Size Growth Rate by Type (2013-2018)
2.4 Pediatric Brain Tumor Segment by Application
2.4.1 Hospitals And Clinics
2.4.2 Medical Research Centers
2.4.3 Academic Institutes
2.5 Pediatric Brain Tumor Market Size by Application
2.5.1 Global Pediatric Brain Tumor Market Size Market Share by Application (2013-2018)
2.5.2 Global Pediatric Brain Tumor Market Size Growth Rate by Application (2013-2018)
3 GLOBAL PEDIATRIC BRAIN TUMOR BY PLAYERS
3.1 Global Pediatric Brain Tumor Market Size Market Share by Players
3.1.1 Global Pediatric Brain Tumor Market Size by Players (2016-2018)
3.1.2 Global Pediatric Brain Tumor Market Size Market Share by Players (2016-2018)
3.2 Global Pediatric Brain Tumor Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 PEDIATRIC BRAIN TUMOR BY REGIONS
4.1 Pediatric Brain Tumor Market Size by Regions
4.2 Americas Pediatric Brain Tumor Market Size Growth
4.3 APAC Pediatric Brain Tumor Market Size Growth
4.4 Europe Pediatric Brain Tumor Market Size Growth
4.5 Middle East & Africa Pediatric Brain Tumor Market Size Growth
5 AMERICAS
5.1 Americas Pediatric Brain Tumor Market Size by Countries
5.2 Americas Pediatric Brain Tumor Market Size by Type
5.3 Americas Pediatric Brain Tumor Market Size by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Pediatric Brain Tumor Market Size by Countries
6.2 APAC Pediatric Brain Tumor Market Size by Type
6.3 APAC Pediatric Brain Tumor Market Size by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries
7 EUROPE
7.1 Europe Pediatric Brain Tumor by Countries
7.2 Europe Pediatric Brain Tumor Market Size by Type
7.3 Europe Pediatric Brain Tumor Market Size by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Pediatric Brain Tumor by Countries
8.2 Middle East & Africa Pediatric Brain Tumor Market Size by Type
8.3 Middle East & Africa Pediatric Brain Tumor Market Size by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 GLOBAL PEDIATRIC BRAIN TUMOR MARKET FORECAST
10.1 Global Pediatric Brain Tumor Market Size Forecast (2018-2023)
10.2 Global Pediatric Brain Tumor Forecast by Regions
10.2.1 Global Pediatric Brain Tumor Forecast by Regions (2018-2023)
10.2.2 Americas Market Forecast
10.2.3 APAC Market Forecast
10.2.4 Europe Market Forecast
10.2.5 Middle East & Africa Market Forecast
10.3 Americas Forecast by Countries
10.3.1 United States Market Forecast
10.3.2 Canada Market Forecast
10.3.3 Mexico Market Forecast
10.3.4 Brazil Market Forecast
10.4 APAC Forecast by Countries
10.4.1 China Market Forecast
10.4.2 Japan Market Forecast
10.4.3 Korea Market Forecast
10.4.4 Southeast Asia Market Forecast
10.4.5 India Market Forecast
10.4.6 Australia Market Forecast
10.5 Europe Forecast by Countries
10.5.1 Germany Market Forecast
10.5.2 France Market Forecast
10.5.3 UK Market Forecast
10.5.4 Italy Market Forecast
10.5.5 Russia Market Forecast
10.5.6 Spain Market Forecast
10.6 Middle East & Africa Forecast by Countries
10.6.1 Egypt Market Forecast
10.6.2 South Africa Market Forecast
10.6.3 Israel Market Forecast
10.6.4 Turkey Market Forecast
10.6.5 GCC Countries Market Forecast
10.7 Global Pediatric Brain Tumor Forecast by Type
10.8 Global Pediatric Brain Tumor Forecast by Application
11 KEY PLAYERS ANALYSIS
11.1 Abbott
11.1.1 Company Details
11.1.2 Pediatric Brain Tumor Product Offered
11.1.3 Abbott Pediatric Brain Tumor Revenue, Gross Margin and Market Share (2016-2018)
11.1.4 Main Business Overview
11.1.5 Abbott News
11.2 AbbVie
11.2.1 Company Details
11.2.2 Pediatric Brain Tumor Product Offered
11.2.3 AbbVie Pediatric Brain Tumor Revenue, Gross Margin and Market Share (2016-2018)
11.2.4 Main Business Overview
11.2.5 AbbVie News
11.3 Akorn
11.3.1 Company Details
11.3.2 Pediatric Brain Tumor Product Offered
11.3.3 Akorn Pediatric Brain Tumor Revenue, Gross Margin and Market Share (2016-2018)
11.3.4 Main Business Overview
11.3.5 Akorn News
11.4 Agios
11.4.1 Company Details
11.4.2 Pediatric Brain Tumor Product Offered
11.4.3 Agios Pediatric Brain Tumor Revenue, Gross Margin and Market Share (2016-2018)
11.4.4 Main Business Overview
11.4.5 Agios News
11.5 Baxter
11.5.1 Company Details
11.5.2 Pediatric Brain Tumor Product Offered
11.5.3 Baxter Pediatric Brain Tumor Revenue, Gross Margin and Market Share (2016-2018)
11.5.4 Main Business Overview
11.5.5 Baxter News
11.6 Bayer
11.6.1 Company Details
11.6.2 Pediatric Brain Tumor Product Offered
11.6.3 Bayer Pediatric Brain Tumor Revenue, Gross Margin and Market Share (2016-2018)
11.6.4 Main Business Overview
11.6.5 Bayer News
11.7 Epizyme
11.7.1 Company Details
11.7.2 Pediatric Brain Tumor Product Offered
11.7.3 Epizyme Pediatric Brain Tumor Revenue, Gross Margin and Market Share (2016-2018)
11.7.4 Main Business Overview
11.7.5 Epizyme News
11.8 Novartis
11.8.1 Company Details
11.8.2 Pediatric Brain Tumor Product Offered
11.8.3 Novartis Pediatric Brain Tumor Revenue, Gross Margin and Market Share (2016-2018)
11.8.4 Main Business Overview
11.8.5 Novartis News
11.9 Mylan
11.9.1 Company Details
11.9.2 Pediatric Brain Tumor Product Offered
11.9.3 Mylan Pediatric Brain Tumor Revenue, Gross Margin and Market Share (2016-2018)
11.9.4 Main Business Overview
11.9.5 Mylan News
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Pediatric Brain Tumor Market Size 2013-2023
2.1.2 Pediatric Brain Tumor Market Size CAGR by Region
2.2 Pediatric Brain Tumor Segment by Type
2.2.1 Gliomas
2.2.2 Mixed Neuronal-Glial Tumors
2.2.3 Embryonal Tumors
2.2.4 Choroid Plexus Papilloma/Carcinoma
2.2.5 Tumors Arising From Non-Neuroepithelial Tissue
2.2.6 Meningeal Tumors
2.3 Pediatric Brain Tumor Market Size by Type
2.3.1 Global Pediatric Brain Tumor Market Size Market Share by Type (2013-2018)
2.3.2 Global Pediatric Brain Tumor Market Size Growth Rate by Type (2013-2018)
2.4 Pediatric Brain Tumor Segment by Application
2.4.1 Hospitals And Clinics
2.4.2 Medical Research Centers
2.4.3 Academic Institutes
2.5 Pediatric Brain Tumor Market Size by Application
2.5.1 Global Pediatric Brain Tumor Market Size Market Share by Application (2013-2018)
2.5.2 Global Pediatric Brain Tumor Market Size Growth Rate by Application (2013-2018)
3 GLOBAL PEDIATRIC BRAIN TUMOR BY PLAYERS
3.1 Global Pediatric Brain Tumor Market Size Market Share by Players
3.1.1 Global Pediatric Brain Tumor Market Size by Players (2016-2018)
3.1.2 Global Pediatric Brain Tumor Market Size Market Share by Players (2016-2018)
3.2 Global Pediatric Brain Tumor Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 PEDIATRIC BRAIN TUMOR BY REGIONS
4.1 Pediatric Brain Tumor Market Size by Regions
4.2 Americas Pediatric Brain Tumor Market Size Growth
4.3 APAC Pediatric Brain Tumor Market Size Growth
4.4 Europe Pediatric Brain Tumor Market Size Growth
4.5 Middle East & Africa Pediatric Brain Tumor Market Size Growth
5 AMERICAS
5.1 Americas Pediatric Brain Tumor Market Size by Countries
5.2 Americas Pediatric Brain Tumor Market Size by Type
5.3 Americas Pediatric Brain Tumor Market Size by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Pediatric Brain Tumor Market Size by Countries
6.2 APAC Pediatric Brain Tumor Market Size by Type
6.3 APAC Pediatric Brain Tumor Market Size by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries
7 EUROPE
7.1 Europe Pediatric Brain Tumor by Countries
7.2 Europe Pediatric Brain Tumor Market Size by Type
7.3 Europe Pediatric Brain Tumor Market Size by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Pediatric Brain Tumor by Countries
8.2 Middle East & Africa Pediatric Brain Tumor Market Size by Type
8.3 Middle East & Africa Pediatric Brain Tumor Market Size by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 GLOBAL PEDIATRIC BRAIN TUMOR MARKET FORECAST
10.1 Global Pediatric Brain Tumor Market Size Forecast (2018-2023)
10.2 Global Pediatric Brain Tumor Forecast by Regions
10.2.1 Global Pediatric Brain Tumor Forecast by Regions (2018-2023)
10.2.2 Americas Market Forecast
10.2.3 APAC Market Forecast
10.2.4 Europe Market Forecast
10.2.5 Middle East & Africa Market Forecast
10.3 Americas Forecast by Countries
10.3.1 United States Market Forecast
10.3.2 Canada Market Forecast
10.3.3 Mexico Market Forecast
10.3.4 Brazil Market Forecast
10.4 APAC Forecast by Countries
10.4.1 China Market Forecast
10.4.2 Japan Market Forecast
10.4.3 Korea Market Forecast
10.4.4 Southeast Asia Market Forecast
10.4.5 India Market Forecast
10.4.6 Australia Market Forecast
10.5 Europe Forecast by Countries
10.5.1 Germany Market Forecast
10.5.2 France Market Forecast
10.5.3 UK Market Forecast
10.5.4 Italy Market Forecast
10.5.5 Russia Market Forecast
10.5.6 Spain Market Forecast
10.6 Middle East & Africa Forecast by Countries
10.6.1 Egypt Market Forecast
10.6.2 South Africa Market Forecast
10.6.3 Israel Market Forecast
10.6.4 Turkey Market Forecast
10.6.5 GCC Countries Market Forecast
10.7 Global Pediatric Brain Tumor Forecast by Type
10.8 Global Pediatric Brain Tumor Forecast by Application
11 KEY PLAYERS ANALYSIS
11.1 Abbott
11.1.1 Company Details
11.1.2 Pediatric Brain Tumor Product Offered
11.1.3 Abbott Pediatric Brain Tumor Revenue, Gross Margin and Market Share (2016-2018)
11.1.4 Main Business Overview
11.1.5 Abbott News
11.2 AbbVie
11.2.1 Company Details
11.2.2 Pediatric Brain Tumor Product Offered
11.2.3 AbbVie Pediatric Brain Tumor Revenue, Gross Margin and Market Share (2016-2018)
11.2.4 Main Business Overview
11.2.5 AbbVie News
11.3 Akorn
11.3.1 Company Details
11.3.2 Pediatric Brain Tumor Product Offered
11.3.3 Akorn Pediatric Brain Tumor Revenue, Gross Margin and Market Share (2016-2018)
11.3.4 Main Business Overview
11.3.5 Akorn News
11.4 Agios
11.4.1 Company Details
11.4.2 Pediatric Brain Tumor Product Offered
11.4.3 Agios Pediatric Brain Tumor Revenue, Gross Margin and Market Share (2016-2018)
11.4.4 Main Business Overview
11.4.5 Agios News
11.5 Baxter
11.5.1 Company Details
11.5.2 Pediatric Brain Tumor Product Offered
11.5.3 Baxter Pediatric Brain Tumor Revenue, Gross Margin and Market Share (2016-2018)
11.5.4 Main Business Overview
11.5.5 Baxter News
11.6 Bayer
11.6.1 Company Details
11.6.2 Pediatric Brain Tumor Product Offered
11.6.3 Bayer Pediatric Brain Tumor Revenue, Gross Margin and Market Share (2016-2018)
11.6.4 Main Business Overview
11.6.5 Bayer News
11.7 Epizyme
11.7.1 Company Details
11.7.2 Pediatric Brain Tumor Product Offered
11.7.3 Epizyme Pediatric Brain Tumor Revenue, Gross Margin and Market Share (2016-2018)
11.7.4 Main Business Overview
11.7.5 Epizyme News
11.8 Novartis
11.8.1 Company Details
11.8.2 Pediatric Brain Tumor Product Offered
11.8.3 Novartis Pediatric Brain Tumor Revenue, Gross Margin and Market Share (2016-2018)
11.8.4 Main Business Overview
11.8.5 Novartis News
11.9 Mylan
11.9.1 Company Details
11.9.2 Pediatric Brain Tumor Product Offered
11.9.3 Mylan Pediatric Brain Tumor Revenue, Gross Margin and Market Share (2016-2018)
11.9.4 Main Business Overview
11.9.5 Mylan News
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES AND FIGURES
Table Product Specifications of Pediatric Brain Tumor
Figure Pediatric Brain Tumor Report Years Considered
Figure Market Research Methodology
Figure Global Pediatric Brain Tumor Market Size Growt
Table Product Specifications of Pediatric Brain Tumor
Figure Pediatric Brain Tumor Report Years Considered
Figure Market Research Methodology
Figure Global Pediatric Brain Tumor Market Size Growt